# Filing Detail

Form PRE 14A - Other preliminary proxy statements:
SEC Accession No. 0001140361-23-018330
Filing Date
2023-04-14
Accepted
2023-04-14 06:03:34
Documents
9
Period of Report
2023-06-09

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | PRE 14A | ny20007145x1_pre14a.htm | PRE 14A | 1487748
2 |  | ny20007145x1_barchart01x1.jpg | GRAPHIC | 100862
3 |  | ny20007145x1_barchart02x1.jpg | GRAPHIC | 137359
4 |  | ny20007145x1_barchart03x1.jpg | GRAPHIC | 127458
5 |  | ny20007145x1_pc01x2.jpg | GRAPHIC | 740320
6 |  | ny20007145x1_pc02x2.jpg | GRAPHIC | 668714
7 |  | ny20007145x1_piechart01x1.jpg | GRAPHIC | 91888
8 |  | ny20007145x1_piechart02.jpg | GRAPHIC | 80638
9 |  | ny20007145x1_piechart03.jpg | GRAPHIC | 56918
| Complete submission text file | 0001140361-23-018330.txt |  | 4247477

Mailing Address 100 CARDINAL WAY REDWOOD CITY CA 94063
Business Address 100 CARDINAL WAY REDWOOD CITY CA 94063 (650) 649-1004
Adverum Biotechnologies, Inc. (Filer) CIK: 0001501756 (see all company filings)

EIN.: 205258327 | State of Incorp.: DE | Fiscal Year End: 1231
Type: PRE 14A | Act: 34 | File No.: 001-36579 | Film No.: 23819613
SIC: 2836 Biological Products, (No Diagnostic Substances)